Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-25-002563

Chief Product Strategy Officer gave up 3,326 shares (to pay taxes)

  • Chief Product Strategy Officer acquired 7,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kieffer Tara Lynn Chief Product Strategy Officer 2025-02-12 Grant or award +7,500 36,805 D: show line 1 in the form
Kieffer Tara Lynn Chief Product Strategy Officer 2025-02-12 Shares withheld for taxes −3,326 $5.59 $18,592 33,479 D: show line 2 in the form
Loading xslF345X05/form4.xml…